B Bonnotte Selected Research

B Bonnotte Research Topics

Disease

5	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 05/2010
4	Neoplasms (Cancer) 01/2002 - 02/2000
3	Hemorrhage 03/2024 - 05/2010
2	Myocarditis (Carditis) 09/2014 - 12/2009
2	Colonic Neoplasms (Colon Cancer) 06/2000 - 05/2000
1	Infections 03/2024
1	Pathologic Complete Response 03/2024
1	Hemophilia A (Haemophilia) 03/2024
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 02/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Giant Cell Arteritis (Horton Disease) 01/2018
1	Aneurysm (Aneurysms) 04/2016
1	Pneumonia (Pneumonitis) 03/2016
1	Healthcare-Associated Pneumonia 03/2016
1	Virilism (Virilization) 01/2016
1	Churg-Strauss Syndrome (Allergic Angiitis) 09/2014
1	Vasculitis (Vasculitides) 09/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2014
1	Cardiomyopathies (Cardiomyopathy) 09/2014
1	Anemia 01/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2012
1	Lupus Nephritis 01/2012
1	Thrombotic Thrombocytopenic Purpura 01/2012
1	Thrombotic Microangiopathies 01/2012
1	Immune System Diseases (Immune Disorders) 05/2010
1	Thrombosis (Thrombus) 12/2009
1	Heart Diseases (Heart Disease) 12/2009
1	Fibrosis (Cirrhosis) 12/2009
1	Pain (Aches) 02/2009
1	Carcinoma (Carcinomatosis) 12/2007
1	Necrosis 12/2007
1	Poisoning 06/2005
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 06/2005
1	Pancreatitis 06/2005
1	Macrophagic myofasciitis 05/2001
1	Hepatocellular Carcinoma (Hepatoma) 11/2000

Drug/Important Bio-Agent (IBA)

4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2024 - 12/2007
4	Inosine Triphosphate (ITP)IBA 01/2021 - 05/2010
4	Proteins (Proteins, Gene)FDA Link 12/2009 - 02/2000
3	SteroidsIBA 03/2024 - 01/2012
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2016 - 06/2000
2	Rituximab (Mabthera)FDA Link 03/2024 - 01/2016
2	GlucocorticoidsIBA 01/2018 - 12/2007
1	Factor VIII (Coagulation Factor VIII)IBA 03/2024
1	AntibodiesIBA 03/2024
1	AutoantibodiesIBA 03/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2018
1	CytokinesIBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	N-hydroxy-2-aminopyreneIBA 03/2016
1	Dapsone FDA Link 01/2016
1	Vinca AlkaloidsIBA 01/2016
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2016
1	Thrombopoietin ReceptorsIBA 01/2016
1	eltrombopag FDA Link 01/2016
1	romiplostim FDA Link 01/2016
1	Danazol (Azol)FDA LinkGeneric 01/2016
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2014
1	thiamine triphosphorate (TTP)IBA 01/2012
1	Hydromorphone (Dilaudid)FDA LinkGeneric 02/2009
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 12/2007
1	Nicotine FDA Link 06/2005
1	DNA (Deoxyribonucleic Acid)IBA 06/2005
1	Antiphospholipid AntibodiesIBA 06/2005
1	AluminumIBA 05/2001
1	VaccinesIBA 05/2001
1	Cyproterone AcetateIBA 11/2000
1	AntigensIBA 06/2000
1	flt3 ligand protein (flt3 ligand)IBA 06/2000
1	Fas Ligand Protein (Fas Ligand)IBA 05/2000
1	Messenger RNA (mRNA)IBA 05/2000
1	Neoplasm Antigens (Tumor Antigens)IBA 02/2000
1	Fluorescein-5-isothiocyanate (FITC)IBA 02/2000

Therapy/Procedure

2	Therapeutics 01/2016 - 02/2009
1	Off-Label Use 02/2022
1	Home Nursing (Nursing, Home) 03/2016
1	Critical Care (Surgical Intensive Care) 03/2016
1	Plasma Exchange 01/2012
1	Intravenous Infusions 12/2007
1	Immunotherapy 12/2007
1	Tobacco Use Cessation Devices 06/2005
1	Radiotherapy 01/2002
1	Blood Transfusion (Blood Transfusions) 01/2002
1	Drug Therapy (Chemotherapy) 01/2002
1	Intramuscular Injections 05/2001